Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$566,386
+$203,758 QoQ
Shares Held
3,614
+52.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#834
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Avail Investment Partners, LLC holds $5,692,157 across 10 Drug Manufacturers - General names. NVS ranks #4 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,595 | $1,420,962 | |
| 2 | LLY |
ELI LILLY & Co
|
534 | $640,495 | |
| 3 | ABBV |
AbbVie Inc.
|
2,253 | $566,944 | |
| 4 | NVS |
Novartis AG
This page
|
3,614 | $566,386 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
9,746 | $561,564 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,244 | $545,354 | |
| 7 | AMGN |
Amgen Inc
|
1,302 | $471,480 | |
| 8 | PFE |
Pfizer Inc
|
15,747 | $379,187 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $566,386 | 3,614 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $362,628 | 2,374 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||